Publication & Citation Trends
Publications
99 total
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
Cited by 152
OpenAlex
Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer OA
Cited by 4
Semantic Scholar
IPSOS: A Phase III, Global, Multicentre, Open-Label, Randomised, Controlled Study of First-Line Atezolizumab Versus Single-Agent Chemotherapy in Patients with Non-Small Cell Lung Cancer Ineligible for Treatment with a Platinum-Containing Regimen
Cited by 2
Semantic Scholar
Safety and efficacy of atezolizumab (atezo) in patients (pts) with autoimmune disease (AID): Subgroup analysis of the TAIL study.
Cited by 0
Semantic Scholar
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors OA
Cited by 1
Semantic Scholar
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors OA
Cited by 91
Semantic Scholar
Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors OA
Cited by 24
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(42)
Breast Cancer Treatment Studies
(35)
Cancer-related Molecular Pathways
(23)
Cancer Immunotherapy and Biomarkers
(12)
Bioinformatics and Genomic Networks
(11)
Affiliations
Roche (Switzerland)
Oslo University Hospital
University of Oslo
Breast Cancer Research Foundation
University of Cambridge